The approval of very long-acting cabotegravir injected after just about every two months expands biomedical HIV prevention options available to people in The usa, delivering a substitute for each day oral capsules. getting unsafe injections, blood transfusions and tissue transplantation, and clinical procedures that require unsterile cutting or piercing; and https://www.directivepublications.org/journal-of-hiv-aids-research/